Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions.

Saved in:
Bibliographic Details
Title: Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions.
Authors: Wong, Angel Kwan Qi1 (AUTHOR), Khan, Saqib Raza2,3 (AUTHOR), Hadi, Danial Khan2,3 (AUTHOR), Breadner, Daniel2,3 (AUTHOR), Vincent, Mark David2,3 (AUTHOR) mark.vincent@lhsc.on.ca
Source: Current Oncology. Jan2026, Vol. 31 Issue 1, p55. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first